BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Protein tyrosine phosphatase type IVA 1 (PTP4A1; PRL1)

August 11, 2016 7:00 AM UTC

Patient sample, cell culture and mouse studies suggest inhibition of PTP4A1 could help treat melanoma. In patient tumor samples, levels of PTP4A1 were higher than in healthy skin samples, and the high...